严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行：后遗症是更大的威胁吗？
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?
作者信息
Rai Nitin, Baidya Dalim Kumar
机构信息
Fortis Escorts Heart Institute, New Delhi, India.
All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Crit Care Med. 2021 Feb;25(2):245-246. doi: 10.5005/jp-journals-10071-23734.
Abstract
Rai N, Baidya DK. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat? Indian J Crit Care Med 2021;25(2):245-246.
摘要
拉伊 N、拜迪亚 DK。严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）大流行：后遗症是更大的威胁吗？《印度重症监护医学杂志》2021 年；25(2):245 - 246。
相似文献
1
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行：后遗症是更大的威胁吗？
Indian J Crit Care Med. 2021 Feb;25(2):245-246. doi: 10.5005/jp-journals-10071-23734.
2
SARS-CoV-2 Infection Presenting with Hyperglycemia and Ketosis: A Case Series of Three Diabetic Patients.新型冠状病毒肺炎合并高血糖和酮症：3例糖尿病患者的病例系列
Indian J Crit Care Med. 2020 Nov;24(11):1141-1142. doi: 10.5005/jp-journals-10071-23595.
3
A Proposal for Dedicated "Prone Team" and "Prone Bundle of Care" in COVID-19 ICU.关于在新冠病毒感染重症监护病房设立专门“俯卧位团队”和“俯卧位护理包”的提议
Indian J Crit Care Med. 2021 Mar;25(3):349-350. doi: 10.5005/jp-journals-10071-23754.
4
Risk of SARS-CoV-2 Infection among Healthcare Providers Involved in Cardiopulmonary Resuscitation in COVID-19 Patients.参与新冠肺炎患者心肺复苏的医护人员感染新冠病毒的风险
Indian J Crit Care Med. 2021 Aug;25(8):920-922. doi: 10.5005/jp-journals-10071-23924.
5
Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management.新冠康复患者的肺纤维化：问题与潜在管理
Indian J Crit Care Med. 2021 Feb;25(2):242-244. doi: 10.5005/jp-journals-10071-23733.
6
Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.严重急性呼吸综合征冠状病毒 2 在人呼吸道上皮细胞中的复制。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.00957-20.
7
Respiratory Care for Severe COVID-19.重症新型冠状病毒肺炎的呼吸治疗
Indian J Crit Care Med. 2020 Jul;24(7):493-495. doi: 10.5005/jp-journals-10071-23509.
8
COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation.一名患有脑病和神经病变的青春期女孩出现与COVID-19相关的儿童严重多系统炎症综合征，预后良好：一种不寻常的表现。
Indian J Crit Care Med. 2020 Dec;24(12):1276-1278. doi: 10.5005/jp-journals-10071-23685.
9
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).SARS 和 2019 冠状病毒病（COVID-19）的甲状腺并发症。
Endocr J. 2021 Feb 28;68(2):129-136. doi: 10.1507/endocrj.EJ20-0443. Epub 2021 Jan 19.
10
Aftermath of COVID-19 and Critical Care in India.印度的新冠疫情后果与重症护理
Indian J Crit Care Med. 2021 Oct;25(10):1173-1175. doi: 10.5005/jp-journals-10071-23987.
本文引用的文献
1
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
2
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.COVID-19 患者出院时的肺功能异常。
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01217-2020. Print 2020 Jun.
3
[Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].[2019冠状病毒病所致肺纤维化机制及相应治疗措施的研究进展]
Zhonghua Shao Shang Za Zhi. 2020 Aug 20;36(8):691-697. doi: 10.3760/cma.j.cn501120-20200307-00132.
4
Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis.特发性肺纤维化的预后与随访
Med Sci (Basel). 2018 Jun 14;6(2):51. doi: 10.3390/medsci6020051.
5
Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis.白细胞介素-6信号在肺纤维化发病机制中的双向作用。
Respir Res. 2015 Aug 20;16(1):99. doi: 10.1186/s12931-015-0261-z.
Zotero 插件